Abstract
AbstractThe hybrid perventricular approach for the closure of trabecular ventricular septal defects is an attractive treatment modality for small children. Worldwide experience has shown that procedure success is influenced by the defect anatomical accessibility, operators’ expertise, and device technical features. In May 2018, a new promising device, the KONAR-Multi-functional™ ventricular septal defect occluder (Lifetech, Shenzhen, China), obtained CE-marking for septal defect transcatheter closure after the first-in-man implantation in 2013. Herein, this is the first report of successful perventricular closure of ventricular septal defect using this new device in a child with significant co-morbidities.
Publisher
Cambridge University Press (CUP)
Subject
Cardiology and Cardiovascular Medicine,General Medicine,Pediatrics, Perinatology, and Child Health
Reference9 articles.
1. A hybrid technique for ventricular septal defect closure in young infants;Bartel;Catheter Cardiovasc Interv,2017
2. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first middle-eastern experience;Haddad;Catheter Cardiovasc Interv,2019
3. Acute and midterm results following perventricular device closure of muscular ventricular septal defects: a multicenter PICES investigation;Gray;Catheter Cardiovasc Interv,2017
4. Perventricular device closure of residual muscular ventricular septal defects after repair of complex congenital heart defects in pediatric patients;Zhu;Tex Heart Inst J,2013
5. Utilizing hybrid techniques to maximize clinical outcomes in congenital heart disease;Bearl;Curr Cardiol Rep,2017
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献